Skip to main content
Premium Trial:

Request an Annual Quote

Florian Heupel, David Mahoney, Peter Bell, Richard de Silva, Mason Morfit

Premium
Florian Heupel has become CEO of MWG-Biotech, a member of the Eurofins Scientific group. He joined Eurofins Scientific as group marketing director in Brussels in 2002. In addition, he has served as CEO of GeneScan Europe, another Eurofins business, since 2004. Heupel holds a PhD in organic chemistry from the University of Oxford and an undergraduate degree in chemistry from the University of Bonn in Germany.
 

 
David Mahoney has become director of global intellectual property and US legal affairs for Febit, the company said last week, a new position. He will be based on Febit’s US offices. Previously, he was US director of legal affairs for Sygnis Pharma.
 

 
Peter Bell and Richard de Silva have been promoted to general partners at Highland Capital Partners, the company said last week. Highland Capital Partners is an investor of Helicos BioSciences.
 

 
Mason Morfit has joined Advanced Medical Optics’ board of directors, the company said last week. He is a partner at San Francisco-based ValueAct Capital Partners and a former director of Solexa. Morfit holds a bachelor's degree from Princeton University.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.